Research ArticleClinical Investigation
Open Access
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti and Liliana Belgioia
Journal of Nuclear Medicine August 2024, 65 (8) 1202-1209; DOI: https://doi.org/10.2967/jnumed.124.267586
Matteo Bauckneht
1Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy;
2Department of Health Sciences, University of Genova, Genova, Italy;
Francesco Lanfranchi
2Department of Health Sciences, University of Genova, Genova, Italy;
Domenico Albano
3Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy;
4University of Brescia, Brescia, Italy;
Luca Triggiani
4University of Brescia, Brescia, Italy;
5Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy;
Flavia Linguanti
6Nuclear Medicine, Careggi University Hospital, Florence, Italy;
7Nuclear Medicine, Ospedale San Donato, Arezzo, Italy;
Luca Urso
8Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy;
Rosario Mazzola
9Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy;
Alessio Rizzo
10Nuclear Medicine, Candiolo Cancer Institute, FPO–IRCCS, Turin, Italy;
Elisa D’Angelo
11Radiation Oncology, University Hospital of Modena, Modena, Italy;
Francesco Dondi
3Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy;
4University of Brescia, Brescia, Italy;
Eneida Mataj
4University of Brescia, Brescia, Italy;
5Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy;
Gloria Pedersoli
4University of Brescia, Brescia, Italy;
5Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy;
Elisabetta Maria Abenavoli
6Nuclear Medicine, Careggi University Hospital, Florence, Italy;
Luca Vaggelli
6Nuclear Medicine, Careggi University Hospital, Florence, Italy;
Beatrice Detti
12Radiation Oncology, Careggi University Hospital, Florence, Italy;
Naima Ortolan
8Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy;
Antonio Malorgio
13Radiotherapy, University Hospital of Ferrara, Ferrara, Italy;
Alessia Guarneri
14Radiation Oncology, Candiolo Cancer Institute, FPO–IRCCS, Turin, Italy;
Federico Garrou
15Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy;
Matilde Fiorini
9Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy;
Serena Grimaldi
15Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy;
Pietro Ghedini
16Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy;
Giuseppe Carlo Iorio
17Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy;
Antonella Iudicello
16Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy;
Guido Rovera
15Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy;
Giuseppe Fornarini
18Medical Oncology 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy;
Diego Bongiovanni
17Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy;
Michela Marcenaro
19Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and
Filippo Maria Pazienza
15Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy;
Giorgia Timon
19Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and
Matteo Salgarello
20Nuclear Medicine, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy
Manuela Racca
10Nuclear Medicine, Candiolo Cancer Institute, FPO–IRCCS, Turin, Italy;
Mirco Bartolomei
8Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy;
Stefano Panareo
16Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy;
Umberto Ricardi
17Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy;
Francesco Bertagna
3Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy;
4University of Brescia, Brescia, Italy;
Filippo Alongi
4University of Brescia, Brescia, Italy;
9Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy;
Salvina Barra
19Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and
Silvia Morbelli
15Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy;
Gianmario Sambuceti
1Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy;
2Department of Health Sciences, University of Genova, Genova, Italy;
Liliana Belgioia
2Department of Health Sciences, University of Genova, Genova, Italy;
19Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 8
August 1, 2024
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti, Liliana Belgioia
Journal of Nuclear Medicine Aug 2024, 65 (8) 1202-1209; DOI: 10.2967/jnumed.124.267586
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, Luca Triggiani, Flavia Linguanti, Luca Urso, Rosario Mazzola, Alessio Rizzo, Elisa D’Angelo, Francesco Dondi, Eneida Mataj, Gloria Pedersoli, Elisabetta Maria Abenavoli, Luca Vaggelli, Beatrice Detti, Naima Ortolan, Antonio Malorgio, Alessia Guarneri, Federico Garrou, Matilde Fiorini, Serena Grimaldi, Pietro Ghedini, Giuseppe Carlo Iorio, Antonella Iudicello, Guido Rovera, Giuseppe Fornarini, Diego Bongiovanni, Michela Marcenaro, Filippo Maria Pazienza, Giorgia Timon, Matteo Salgarello, Manuela Racca, Mirco Bartolomei, Stefano Panareo, Umberto Ricardi, Francesco Bertagna, Filippo Alongi, Salvina Barra, Silvia Morbelli, Gianmario Sambuceti, Liliana Belgioia
Journal of Nuclear Medicine Aug 2024, 65 (8) 1202-1209; DOI: 10.2967/jnumed.124.267586
Jump to section
Related Articles
Cited By...
- PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
- Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
- One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study
- Reply: One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study and Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study